Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
PUMA is an observational, multicentre, multinational, cross-sectional study with primary care physicians (primary care, general and family physicians). Participants will be selected sequentially among patients at risk for Chronic Obstructive Pulmonary Disease (COPD) who attend primary care consultation (primary care, general and family physicians). The inclusion visit will be a regularly scheduled or spontaneous consultation for patients, and this appointment with the physician will not depend on the study. During the appointment, data will be collected from the patient and the physician.
PREVALENCE STUDY AND REGULAR PRACTICE (DIAGNOSIS AND TREATMENT) AMONG GENERAL PRACTICIONERS IN POPULATIONS AT RISK OF COPD IN LATIN AMERICA
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with an affirmative response to specific categories on the PUMA questionnaire. | PUMA Questionnaire: Based on the PLATINO questionnaire. Applied to patients to describe different aspects potentially related to Chronic Obstructive Pulmonary Disease (COPD) such as: respiratory symptoms, smoking, respiratory medication, health care resources usage, comorbidieties, etc., as well as the registration of procedures (spirometry and oximetry) carried out and anthropometric data. | Baseline |
| FEV1 spirometry measures. | FEV1 is the volume of air expelled from the lungs in 1 second. The second visit will be scheduled only for those patients who do not meet criteria for deferring spirometry. | Baseline and visit 2 up to 4 weeks after baseline (if applicable) |
| SaO2 (Arterial Oxygen Saturation) - pulse oximetry. | The second visit will be scheduled only for those patients who do not meet criteria for deferring spirometry. | Baseline and visit 2 up to 4 weeks after baseline (if applicable) |
| Number of participants with an affirmative response to specific categories on the Medical History Questionnaire (if applicable). | Questionnaire based on the patient's personal medical history at the site. Its application will be subject to the existence of a prior medical history for the patient at site. If the patient has no prior medical history at site, then this questionnaire will not apply. | Baseline |
| FEV1/FVC spirometry measures. | Ratio of Forced Expiratory Volume in 1 second (volume of air expelled from the lungs in 1 second) by the Forced Vital Capacity (FVC, the volume of air that can forcibly be blown out after full inspiration) is a spirometric measure (lung function test) used to demonstrate airway obstruction. The second visit will be scheduled only for those patients who do not meet criteria for deferring spirometry. |
Not provided
Not provided
Inclusion Criteria:
Cigarettes: more or equal than 10 packs/year; Pipes: more or equal than 50 pipes/year; Cigars: more or equal than 50 cigars/year; Combustion: more or equal 100 hours/firewood/year
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients aged 40 or more, smokers or former smokers and/or people exposed to biomass combustion, who attend primary care consultation.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Maria Montes de Oca, Internist - Pulmonologist | Universidad Central de Venezuela | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Belen de Escobar | Buenos Aires | Argentina | |||
| Research Site |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 27319305 | Derived | Lopez Varela MV, Montes de Oca M, Rey A, Casas A, Stirbulov R, Di Boscio V; PUMA Team. Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: The PUMA study. Respirology. 2016 Oct;21(7):1227-34. doi: 10.1111/resp.12834. Epub 2016 Jun 20. |
Not provided
Not provided
Not provided
Not provided
Not provided
| Baseline and visit 2 up to 4 weeks after baseline (if applicable) |
| Heart rate (HR) - pulse oximetry. | The second visit will be scheduled only for those patients who do not meet criteria for deferring spirometry. | Baseline and visit 2 up to 4 weeks after baseline (if applicable) |
| Ezeiza |
| Buenos Aires |
| Argentina |
| Research Site | Los Polvorines | Buenos Aires | Argentina |
| Research Site | Martínez | Buenos Aires | Argentina |
| Research Site | Quilmes | Buenos Aires | Argentina |
| Research Site | Ramos Mejía | Buenos Aires | Argentina |
| Research Site | Capital Federal | Buenos Aires F.D. | Argentina |
| Research Site | Medellín | Antioquia | Colombia |
| Research Site | Barranquilla | Atlántico | Colombia |
| Research Site | Manizales | Caldas Department | Colombia |
| Research Site | Armenia | Quindío Department | Colombia |
| Research Site | Cali | Valle del Cauca Department | Colombia |
| Research Site | Montevideo | Montevideo Department | Uruguay |
| Research Site | Barquisimeto | Venezuela |
| Research Site | Caracas | Venezuela |
| Research Site | Maracaibo | Venezuela |
| Research Site | Porlamar | Venezuela |
| Research Site | Valencia | Venezuela |
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided